Gender‐affirming hormone therapy and the risk of sex hormone‐dependent tumours in transgender individuals—A systematic review

T McFarlane, JD Zajac, AS Cheung - Clinical endocrinology, 2018 - Wiley Online Library
Background Cancers are a leading cause of death worldwide, and transgender individuals
are no exception. The effects of gender‐affirming hormone therapy (GAHT) on sex hormone …
被引用次数：55 相关文章

Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review.

T McFarlane, JD Zajac, AS Cheung - Clinical Endocrinology, 2018 - europepmc.org
Background Cancers are a leading cause of death worldwide, and transgender individuals
are no exception. The effects of gender-affirming hormone therapy (GAHT) on sex hormone …

Gender‐affirming hormone therapy and the risk of sex hormone‐dependent tumours in transgender individuals—A systematic review.

T McFarlane, JD Zajac, AS Cheung - Clinical Endocrinology, 2018 - search.ebscohost.com
Background: Cancers are a leading cause of death worldwide, and transgender individuals
are no exception. The effects of gender‐affirming hormone therapy (GAHT) on sex hormone …
[PDF] unimelb.edu.au

[PDF][PDF] Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals–a systematic review.

T MacFarlane, JD Zajac, AS Cheung - minerva-access.unimelb.edu.au
Gender‐affirming hormone therapy and the risk of sex hormone‐dependent tumours in
transgender individuals—A systematic rev Page 1 This is the author manuscript accepted for …

Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-a systematic review.

T MacFarlane, JD Zajac, AS Cheung - 2018 - ahro.austin.org.au
Cancers are a leading cause of death worldwide and transgender individuals are no
exception. The effects of gender-affirming hormone therapy (GAHT) on sex hormone …

Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review

T McFarlane, JD Zajac… - Clinical …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Cancers are a leading cause of death worldwide, and transgender individuals
are no exception. The effects of gender-affirming hormone therapy (GAHT) on sex hormone …

Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review

T McFarlane, JD Zajac… - Clinical …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Cancers are a leading cause of death worldwide, and transgender individuals
are no exception. The effects of gender-affirming hormone therapy (GAHT) on sex hormone …